UCSF Weill Institute for Neurosciences - Substance Use Disorders Clinic - Mission Bay — San Francisco, California

UCSF Weill Institute for Neurosciences - Substance Use Disorders Clinic - Mission Bay is a clinical research site located in San Francisco, California, United States 94158.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

UCSF Weill Institute for Neurosciences - Substance Use Disorders Clinic - Mission Bay has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: Opioid Use Disorder, Alcohol Use Disorder.

Sponsors: Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCSF Weill Institute for Neurosciences - Substance Use Disorders Clinic - Mission Bay?

UCSF Weill Institute for Neurosciences - Substance Use Disorders Clinic - Mission Bay has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCSF Weill Institute for Neurosciences - Substance Use Disorders Clinic - Mission Bay conducted?

UCSF Weill Institute for Neurosciences - Substance Use Disorders Clinic - Mission Bay has 3 clinical trials on record, with 3 currently active. Their work covers Opioid Use Disorder, Alcohol Use Disorder.

Is UCSF Weill Institute for Neurosciences - Substance Use Disorders Clinic - Mission Bay accredited by Crixeo Health?

UCSF Weill Institute for Neurosciences - Substance Use Disorders Clinic - Mission Bay has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCSF Weill Institute for Neurosciences - Substance Use Disorders Clinic - Mission Bay?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.